A statistical approach for assessment of bronchodilator responsiveness in pulmonary function testing

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology

Background:

• Current bronchodilator responsiveness criteria rely on population variability.
• Existing methods compare only single best pre- and post-intervention measures.
• This approach may misclassify individual patient responsiveness.

Purpose of the Study:

• To test the hypothesis that individual patient variability in FEV1 and FEV3 is a superior measure of bronchodilator responsiveness.
• To identify a more accurate method for assessing bronchodilator response in patients with obstructive lung diseases.

Main Methods:

• Employed five 3-second forced expiratory maneuvers at baseline, after saline, and after albuterol.
• Included 50 adult patients with obstructive lung diseases (asthma, bronchitis, emphysema) with varying severity.
• Utilized a pulmonary function laboratory setting for routine testing.

Main Results:

• Identified 36 responders with consistent and statistically significant FEV1 and FEV3 improvement post-albuterol.
• FEV3 measures were found to be more reliable for assessing responsiveness than vital capacity.
• 14 non-responders were identified, consistent with all other published criteria.

Conclusions:

• A higher percentage of responders were identified using this variability-based method compared to existing criteria.
• This approach successfully identified responders with very severe or minimal airway obstruction, often missed by other methods.
• Individualized assessment of bronchodilator responsiveness using FEV1 and FEV3 variability offers improved diagnostic accuracy.